data_1u3b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u3b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.681 0.276 . . . . 2.8799999999999999 111.316 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 2.1 m-85 -59.0 138.77 57.38 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.173 -0.467 . . . . 2.3100000000000001 111.274 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.58 126.95 3.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.019 0.438 . . . . 2.1400000000000001 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.68 130.01 41.2 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.792 -0.64 . . . . 2.4300000000000002 109.865 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.573 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 51.1 t -111.82 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 1.6100000000000001 111.036 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -99.23 104.68 16.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 2.5699999999999998 110.525 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -105.87 99.24 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 1.51 110.72 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -81.77 114.54 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 2.8199999999999998 110.025 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -143.37 -171.61 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.392 -0.367 . . . . 2.0499999999999998 111.471 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -104.45 166.99 10.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.254 -0.43 . . . . 2.1800000000000002 110.689 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -67.66 148.61 51.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 2.3700000000000001 110.548 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.515 ' HA2' ' HD3' ' A' ' 94' ' ' LYS . . . 79.0 10.0 86.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.786 -0.721 . . . . 1.0900000000000001 112.598 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LEU . 25.8 mt-10 -119.05 30.07 7.35 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.995 0.398 . . . . 2.6400000000000001 110.392 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG22 ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 17.12 -78.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.619 1.199 . . . . 1.49 113.752 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 29' ' ' GLU . 15.0 tp -179.79 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.573 -0.739 . . . . 1.49 109.948 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 88.83 58.48 1.7 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.562 -0.744 . . . . 0.89000000000000001 113.734 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG21 ' CD1' ' A' ' 201' ' ' ILE . 0.7 OUTLIER -149.37 155.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.142 0.496 . . . . 1.3300000000000001 111.804 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.6 ' HB ' ' CB ' ' A' ' 51' ' ' ASN . 54.3 t -117.42 125.87 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.446 -0.797 . . . . 1.55 109.843 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 1.0 OUTLIER -114.51 150.95 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.096 0.474 . . . . 1.3 112.159 -179.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 30.0 m -139.37 169.92 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 115.458 -0.792 . . . . 1.5900000000000001 110.523 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.11 131.44 45.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.732 0.301 . . . . 2.1600000000000001 110.811 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.544 ' HA ' ' CD1' ' A' ' 48' ' ' ILE . 79.6 p -68.38 85.64 0.28 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.921 -0.581 . . . . 1.3300000000000001 111.511 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.61 0.96 89.38 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.02 -0.609 . . . . 1.4099999999999999 113.725 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.583 ' CH2' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -61.78 -159.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.54 0.336 . . . . 1.6100000000000001 110.56 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -54.21 -22.79 22.98 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.722 -0.752 . . . . 1.3500000000000001 112.363 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m 79.95 42.24 0.06 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.762 0.825 . . . . 1.8200000000000001 111.719 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HB ' ' CH2' ' A' ' 40' ' ' TRP . 84.9 mt -58.02 -38.46 67.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.917 -1.038 . . . . 1.6399999999999999 109.95 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.458 ' HB2' ' HE3' ' A' ' 71' ' ' MET . 11.6 mt -147.91 98.11 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 114.728 -1.124 . . . . 1.73 108.616 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.0 Cg_exo -53.06 90.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.939 2.426 . . . . 1.3799999999999999 113.441 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 71' ' ' MET . 1.5 p -139.59 -154.58 0.53 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.365 -0.379 . . . . 1.73 110.37 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -110.05 139.29 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 1.46 111.338 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -99.25 137.27 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.83 -0.623 . . . . 1.5700000000000001 111.778 -179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.505 HG21 ' HA ' ' A' ' 66' ' ' ILE . 94.3 mt -75.85 90.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.755 -0.832 . . . . 1.3600000000000001 108.755 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.45 -14.94 47.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.919 -1.037 . . . . 1.6200000000000001 112.174 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.6 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -158.29 165.28 35.19 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.889 0.376 . . . . 2.0 111.144 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -153.81 142.72 21.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.057 -0.52 . . . . 1.6000000000000001 110.82 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.48 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 4.7 mtt -56.43 -30.06 62.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.09 -0.504 . . . . 1.74 111.395 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 58.55 58.19 3.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.291 0.567 . . . . 4.25 110.462 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.86 -34.7 0.18 Allowed Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.568 -0.742 . . . . 1.4099999999999999 112.269 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.09 -163.49 7.7 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.117 -0.563 . . . . 1.1599999999999999 112.254 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 32.1 Cg_exo -58.91 -28.84 88.68 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.826 2.351 . . . . 1.4299999999999999 113.559 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -50.15 68.38 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.635 0.255 . . . . 1.3999999999999999 111.312 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -77.97 -36.85 48.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.209 -0.451 . . . . 3.1299999999999999 110.786 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -54.38 -47.23 72.9 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.15 -0.477 . . . . 2.9399999999999999 111.472 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -69.07 -50.47 48.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.326 -0.397 . . . . 2.3700000000000001 110.959 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.27 58.93 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.976 -0.63 . . . . 1.8100000000000001 112.77 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 12.9 mtpt -75.99 -41.9 49.8 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.641 0.258 . . . . 3.1000000000000001 110.951 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HG ' ' CG1' ' A' ' 21' ' ' VAL . 29.5 mt -87.03 120.66 28.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.266 -0.425 . . . . 1.6000000000000001 110.654 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 25.9 m-80 -137.36 158.61 44.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 2.2200000000000002 110.932 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 51' ' ' ASN . 32.6 mm -64.87 143.29 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.975 0.417 . . . . 1.76 111.602 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.84 57.74 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.583 -0.735 . . . . 1.1599999999999999 112.857 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -115.45 146.62 41.47 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.96 0.38 . . . . 1.45 110.08 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' HB3' ' HE2' ' A' ' 71' ' ' MET . 1.9 mt-30 -109.89 124.65 51.72 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.042 0.386 . . . . 1.8700000000000001 112.042 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG12 HG21 ' A' ' 103' ' ' ILE . 6.5 mt -84.48 117.96 30.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.893 -0.594 . . . . 1.3 110.924 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -84.39 -41.43 16.71 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.116 -0.493 . . . . 1.52 111.824 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.2 p -151.24 148.57 28.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.708 0.29 . . . . 1.8899999999999999 111.353 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.52 HG12 HD22 ' A' ' 101' ' ' LEU . 2.2 mp -127.15 109.92 21.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 1.1799999999999999 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 55.5 40.37 31.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.944 -0.571 . . . . 2.1299999999999999 111.554 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.54 -25.45 27.19 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.89 -0.671 . . . . 1.1499999999999999 113.523 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 m -79.4 102.0 8.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.139 0.47 . . . . 1.45 110.767 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m -71.0 111.1 6.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.035 -0.53 . . . . 1.8799999999999999 111.61 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.547 HD21 HD13 ' A' ' 81' ' ' LEU . 10.9 mt -76.91 -17.04 59.18 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.797 -0.638 . . . . 1.3100000000000001 111.215 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 45' ' ' PRO . 15.9 t -62.72 114.85 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.704 -0.225 . . . . 2.0499999999999998 111.118 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.12 -48.1 0.97 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.932 -0.651 . . . . 1.02 113.242 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.547 HD13 HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -77.2 156.39 81.74 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.754 0.311 . . . . 1.77 111.467 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.93 -179.07 2.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.936 2.424 . . . . 1.4199999999999999 113.309 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -66.38 -49.35 67.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.67 -0.696 . . . . 2.21 111.771 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -52.12 -45.62 65.02 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.547 -0.297 . . . . 2.3300000000000001 110.79 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 89' ' ' ILE . 23.1 m -66.46 -45.79 78.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 1.5600000000000001 110.716 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.466 ' HA ' HG13 ' A' ' 89' ' ' ILE . 59.2 m -57.0 -45.55 82.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.606 0.241 . . . . 0.89000000000000001 111.166 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 35' ' ' ILE . 13.6 mt-30 -59.13 -44.06 92.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.399 -0.364 . . . . 2.1499999999999999 110.544 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 t -64.34 -32.72 74.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.422 -0.354 . . . . 2.29 111.054 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.466 HG13 ' HA ' ' A' ' 86' ' ' CYS . 1.1 mm -61.89 -49.86 82.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.317 -0.401 . . . . 1.49 110.801 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' CG2' HD11 ' A' ' 201' ' ' ILE . 49.7 mt -71.99 -43.33 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.288 -0.414 . . . . 1.3 110.774 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' HG3' HG21 ' A' ' 201' ' ' ILE . 8.8 mtpt -55.73 -31.54 62.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.1 -0.5 . . . . 3.3700000000000001 111.099 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.3 -44.3 98.25 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.92 -0.582 . . . . 1.03 112.348 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -88.23 57.73 4.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.263 0.554 . . . . 1.6299999999999999 110.696 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.515 ' HD3' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -87.81 -33.99 18.43 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.557 -0.747 . . . . 2.71 110.859 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.78 61.44 0.81 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.379 -0.373 . . . . 2.5 111.656 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.406 ' NE2' ' HB2' ' A' ' 93' ' ' LEU . 1.2 pt20 -127.34 164.96 20.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.283 -0.417 . . . . 2.6699999999999999 110.735 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.4 p -97.75 -13.83 21.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.482 0.549 . . . . 2.0499999999999998 112.482 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.4 ttm180 -145.62 132.95 20.6 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.282 . . . . 4.8799999999999999 111.176 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.42 ' CG1' HD23 ' A' ' 101' ' ' LEU . 2.0 t -112.99 104.29 16.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.279 -0.419 . . . . 1.48 111.282 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.44 125.56 38.11 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.08 -0.509 . . . . 2.1200000000000001 109.736 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.52 HD22 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -144.39 116.22 8.26 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.015 0.436 . . . . 1.29 112.135 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.56 95.86 10.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.706 -0.849 . . . . 1.6000000000000001 108.706 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.56 HG21 HG12 ' A' ' 70' ' ' ILE . 1.6 pt -118.6 160.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 1.23 112.389 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 81.9 t -102.59 108.0 23.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.773 -0.649 . . . . 1.9399999999999999 109.586 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.427 ' C ' ' HD3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -74.7 116.24 15.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.842 -0.617 . . . . 3.0499999999999998 111.66 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.503 ' N ' ' HD3' ' A' ' 107' ' ' PRO . 17.6 t -129.12 54.84 15.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.747 -0.661 . . . . 2.2400000000000002 110.83 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 106' ' ' CYS . 75.5 Cg_endo -89.93 114.64 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.965 2.443 . . . . 3.4700000000000002 112.703 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.558 ' HD2' ' HG3' ' A' ' 185' ' ' PRO . 21.9 Cg_exo -64.98 111.88 1.86 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.651 2.234 . . . . 2.29 111.863 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 183' ' ' THR . 21.8 t -99.71 123.34 52.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.275 -0.421 . . . . 2.25 111.317 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -106.04 136.3 45.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 1.3300000000000001 110.634 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.8 m -90.91 111.81 23.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 1.52 110.268 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.65 ' HB ' ' HG2' ' A' ' 181' ' ' MET . 38.5 t -91.5 106.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.986 -0.552 . . . . 1.8200000000000001 111.218 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.56 ' HG ' ' CD2' ' A' ' 180' ' ' HIS . 0.9 OUTLIER -102.65 92.78 4.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.167 -0.47 . . . . 1.8999999999999999 109.991 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 141' ' ' ALA . 3.2 mt -105.37 104.47 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.131 0.491 . . . . 1.4099999999999999 111.275 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.38 135.21 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.608 -0.724 . . . . 3.7799999999999998 110.971 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.0 108.54 18.16 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.16 -0.473 . . . . 3.3700000000000001 110.929 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.96 -37.04 35.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.55 2.167 . . . . 2.48 112.473 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -139.79 163.46 32.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.82 0.343 . . . . 2.3300000000000001 111.037 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HG ' HG13 ' A' ' 176' ' ' VAL . 0.5 OUTLIER -70.99 -18.01 62.62 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.094 -0.503 . . . . 2.1600000000000001 111.638 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -93.21 18.87 8.78 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.68 0.252 . . . . 5.0800000000000001 111.68 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -102.35 135.71 43.47 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.749 0.309 . . . . 3.1600000000000001 110.847 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.83 126.4 35.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.136 -0.484 . . . . 2.8700000000000001 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.0 mp -62.35 -49.47 75.46 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.267 -0.424 . . . . 2.1299999999999999 110.951 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.49 55.78 0.62 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.98 -0.628 . . . . 1.71 112.97 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -178.73 171.49 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.726 0.298 . . . . 2.8500000000000001 111.115 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -131.76 127.1 36.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.307 -0.406 . . . . 1.8 110.848 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 168' ' ' ILE . 7.2 p -109.19 128.84 64.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 1.29 111.027 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.21 88.41 2.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.115 -0.493 . . . . 2.98 110.678 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 163' ' ' THR . 1.4 m-80 66.64 -69.79 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.529 -0.76 . . . . 2.4700000000000002 111.966 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 151' ' ' ARG . . . -139.04 -3.32 1.72 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.363 -0.922 . . . . 1.51 114.065 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.531 HD13 ' HG3' ' A' ' 151' ' ' ARG . 26.0 mm -123.76 150.7 28.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 117.822 0.811 . . . . 2.0299999999999998 111.586 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.44 HD12 HG13 ' A' ' 152' ' ' ILE . 5.0 mp -99.76 137.36 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.793 -0.639 . . . . 1.3200000000000001 110.712 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -119.59 -59.49 1.81 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.397 -0.365 . . . . 2.1800000000000002 111.559 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -89.08 154.21 20.36 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.839 0.352 . . . . 2.0 111.29 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -164.63 127.84 2.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.993 -0.549 . . . . 2.3300000000000001 111.031 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 19.6 mtp -78.77 122.25 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.118 -0.492 . . . . 2.8799999999999999 110.707 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -65.08 110.32 2.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.247 -0.433 . . . . 5.3099999999999996 110.858 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.46 27.2 33.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.106 -0.569 . . . . 1.6299999999999999 112.822 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -96.34 -169.83 34.62 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.946 -0.645 . . . . 1.3600000000000001 112.347 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 mt -78.02 -44.81 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.537 0.208 . . . . 1.72 110.942 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -58.9 -44.48 91.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.322 -0.399 . . . . 1.3799999999999999 110.607 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -68.88 -39.48 79.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.001 -0.545 . . . . 2.3199999999999998 111.057 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -39.75 91.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.553 -0.294 . . . . 3.8999999999999999 111.495 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.6 -66.1 2.71 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.155 -0.545 . . . . 0.87 112.834 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.07 -31.76 0.03 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.828 -0.701 . . . . 0.80000000000000004 113.699 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -42.78 137.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.93 0.395 . . . . 1.6100000000000001 111.807 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -144.84 143.64 30.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.907 -0.588 . . . . 4.4100000000000001 110.938 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.88 114.22 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.209 -0.45 . . . . 1.8500000000000001 110.385 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 119.33 -20.4 9.64 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 121.082 -0.58 . . . . 1.0700000000000001 112.29 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -71.04 -174.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.962 0.411 . . . . 1.48 110.787 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.531 ' HG3' HD13 ' A' ' 131' ' ' ILE . 2.8 ttt180 -141.13 90.7 2.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 3.4300000000000002 110.623 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.516 ' HA ' HG21 ' A' ' 183' ' ' THR . 19.2 mt -53.5 136.66 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.455 -0.339 . . . . 1.26 110.384 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.93 -84.55 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.951 0.723 . . . . 1.51 112.951 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.42 90.06 7.85 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.204 0.816 . . . . 2.3300000000000001 113.204 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.564 HD11 HG23 ' A' ' 160' ' ' VAL . 1.8 mt -90.48 105.47 16.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 1.3500000000000001 110.735 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 55.03 36.95 28.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.936 -0.575 . . . . 2.02 111.463 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.36 -3.5 79.48 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.958 -0.639 . . . . 1.4399999999999999 113.72 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -108.53 115.48 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.25 0.525 . . . . 2.5 110.84 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.22 107.94 7.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.197 -0.456 . . . . 2.4399999999999999 111.027 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.564 HG23 HD11 ' A' ' 155' ' ' ILE . 15.4 m -102.21 3.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 1.74 111.828 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.4 p -51.24 -37.93 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.58 0.228 . . . . 1.98 111.468 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.73 30.91 6.76 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.932 0.396 . . . . 1.99 110.608 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.496 HG21 ' HD3' ' A' ' 167' ' ' LYS . 73.3 m -111.62 143.74 29.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.059 -0.519 . . . . 1.6899999999999999 110.987 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.408 ' HD2' HG21 ' A' ' 163' ' ' THR . 51.7 Cg_exo -54.8 154.0 22.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.024 2.483 . . . . 1.6299999999999999 112.961 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -62.45 -39.38 93.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.067 -0.515 . . . . 2.5099999999999998 111.916 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.02 -38.6 89.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.718 -0.219 . . . . 2.9500000000000002 111.388 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.496 ' HD3' HG21 ' A' ' 163' ' ' THR . 0.2 OUTLIER -65.63 -50.23 65.77 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.441 -0.345 . . . . 3.0099999999999998 111.077 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.493 HD13 HG23 ' A' ' 168' ' ' ILE . 8.6 mt -58.23 -46.4 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.83 0.348 . . . . 1.49 110.824 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 t -60.32 -32.81 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.863 -0.608 . . . . 1.54 110.459 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -64.09 -51.05 65.89 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.575 -0.284 . . . . 2.7000000000000002 111.344 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.444 ' CD1' ' O ' ' A' ' 167' ' ' LYS . 3.6 mp -53.66 -56.37 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.827 0.346 . . . . 1.49 110.236 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.596 HD23 HG12 ' A' ' 179' ' ' ILE . 1.9 mt -61.24 -30.85 70.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.478 -0.783 . . . . 1.29 111.26 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.1 t -69.98 -26.97 64.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.702 -0.226 . . . . 2.23 110.748 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -125.69 28.55 6.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.609 -0.269 . . . . 1.8799999999999999 111.69 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 179' ' ' ILE . . . -109.69 52.1 0.73 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.916 0.389 . . . . 1.5900000000000001 110.951 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.436 HG13 ' HG ' ' A' ' 119' ' ' LEU . 7.5 m -59.17 137.45 21.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.033 -0.53 . . . . 2.0899999999999999 111.495 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 126.71 -98.16 0.51 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.823 -0.626 . . . . 1.1499999999999999 112.121 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -148.08 93.41 2.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.753 0.311 . . . . 2.3100000000000001 110.827 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.596 HG12 HD23 ' A' ' 172' ' ' LEU . 1.7 mt -71.37 113.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.317 -0.402 . . . . 1.3899999999999999 110.777 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.56 ' CD2' ' HG ' ' A' ' 113' ' ' LEU . 23.6 m170 -112.62 115.28 28.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 4.2300000000000004 109.917 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.65 ' HG2' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -138.98 169.23 18.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.135 0.493 . . . . 1.8200000000000001 112.205 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 148.05 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.383 -0.826 . . . . 2.7000000000000002 109.66 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 152' ' ' ILE . 70.6 p -136.21 125.41 24.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 1.3 111.525 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -96.07 178.52 1.39 Allowed Pre-proline 0 C--O 1.224 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.8999999999999999 110.274 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.558 ' HG3' ' HD2' ' A' ' 108' ' ' PRO . 70.0 Cg_endo -88.23 125.08 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.248 1.965 . . . . 1.75 112.303 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.49 ' HB1' HD12 ' A' ' 131' ' ' ILE . . . -82.51 -167.4 1.59 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.472 -0.331 . . . . 1.9399999999999999 111.057 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -56.85 148.96 19.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.528 -0.305 . . . . 3.1899999999999999 111.409 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.7 132.86 49.02 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 6.9800000000000004 111.325 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 191' ' ' LEU . 47.2 t80 -89.59 120.13 30.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.971 -0.558 . . . . 8.5199999999999996 110.619 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -104.21 60.93 0.72 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.27 -0.423 . . . . 9.0800000000000001 111.131 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 191' ' ' LEU . 0.0 OUTLIER 29.24 -90.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.76 0.824 . . . . 7.2199999999999998 112.606 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.74 -45.25 0.74 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.45 0.167 . . . . 7.46 111.224 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.2 p -61.76 169.58 2.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.812 0.339 . . . . 6.8799999999999999 111.55 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 69.9 80.53 0.18 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.989 -0.551 . . . . 6.2800000000000002 111.087 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 -33.21 21.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.924 -0.58 . . . . 7.2300000000000004 111.295 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.84 145.22 40.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.784 0.326 . . . . 5.9400000000000004 110.939 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.37 138.28 63.88 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.117 -0.492 . . . . 4.6600000000000001 110.977 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.429 ' HG2' ' CG2' ' A' ' 34' ' ' VAL . 36.8 Cg_endo -65.83 167.4 17.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.762 2.308 . . . . 2.0099999999999998 112.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 87.6 t -56.49 120.22 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.163 -0.471 . . . . 2.6299999999999999 111.063 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.411 ' CD1' HG21 ' A' ' 34' ' ' VAL . 7.9 m-85 -105.27 112.56 25.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.136 -0.484 . . . . 2.4900000000000002 111.338 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.529 ' CD1' HG21 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.433 -0.794 . . . . 1.46 111.418 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.681 0.276 . . . . 2.8799999999999999 111.316 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 2.1 m-85 -59.0 138.77 57.38 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.173 -0.467 . . . . 1.49 111.274 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.58 126.95 3.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.019 0.438 . . . . 1.6299999999999999 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.68 130.01 41.2 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.792 -0.64 . . . . 2.4300000000000002 109.865 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.892 HG11 ' HG ' ' A' ' 64' ' ' LEU . 51.1 t -111.82 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 1.1000000000000001 111.036 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -99.23 104.68 16.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 1.8600000000000001 110.525 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 99' ' ' VAL . 8.4 mm -105.87 99.24 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 1.1100000000000001 110.72 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HG3' ' CD ' ' A' ' 98' ' ' ARG . 2.8 mp0 -81.77 114.54 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 2.8199999999999998 110.025 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -143.37 -171.61 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.392 -0.367 . . . . 1.52 111.471 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -104.45 166.99 10.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.254 -0.43 . . . . 2.1400000000000001 110.689 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -67.66 148.61 51.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 1.95 110.548 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 94' ' ' LYS . . . 79.0 10.0 86.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.786 -0.721 . . . . 1.0800000000000001 112.598 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LEU . 25.8 mt-10 -119.05 30.07 7.35 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.995 0.398 . . . . 2.6400000000000001 110.392 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.655 HG23 ' CG ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 17.12 -78.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.619 1.199 . . . . 0.97999999999999998 113.752 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 99' ' ' VAL . 15.0 tp -179.79 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.573 -0.739 . . . . 0.93999999999999995 109.948 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 88.83 58.48 1.7 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.562 -0.744 . . . . 0.87 113.734 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.086 HG22 HD11 ' A' ' 201' ' ' ILE . 0.7 OUTLIER -149.37 155.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.142 0.496 . . . . 0.79000000000000004 111.804 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.961 HG21 ' HG2' ' A' ' 198' ' ' PRO . 54.3 t -117.42 125.87 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.446 -0.797 . . . . 1.03 109.843 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -114.51 150.95 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.096 0.474 . . . . 0.89000000000000001 112.159 -179.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 30.0 m -139.37 169.92 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 115.458 -0.792 . . . . 1.1000000000000001 110.523 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.11 131.44 45.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.732 0.301 . . . . 2.1600000000000001 110.811 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.656 ' HA ' HD11 ' A' ' 48' ' ' ILE . 79.6 p -68.38 85.64 0.28 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.921 -0.581 . . . . 1.04 111.511 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.61 0.96 89.38 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.02 -0.609 . . . . 1.4099999999999999 113.725 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.739 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -61.78 -159.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.54 0.336 . . . . 1.3300000000000001 110.56 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -54.21 -22.79 22.98 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.722 -0.752 . . . . 1.26 112.363 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m 79.95 42.24 0.06 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.762 0.825 . . . . 1.52 111.719 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.739 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 84.9 mt -58.02 -38.46 67.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.917 -1.038 . . . . 1.1899999999999999 109.95 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 46' ' ' THR . 11.6 mt -147.91 98.11 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 114.728 -1.124 . . . . 1.1399999999999999 108.616 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.0 Cg_exo -53.06 90.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.939 2.426 . . . . 1.1399999999999999 113.441 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.822 HG22 HG22 ' A' ' 79' ' ' VAL . 1.5 p -139.59 -154.58 0.53 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.365 -0.379 . . . . 1.27 110.37 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -110.05 139.29 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.92000000000000004 111.338 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.656 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -99.25 137.27 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.83 -0.623 . . . . 0.96999999999999997 111.778 -179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.046 HG22 HD13 ' A' ' 66' ' ' ILE . 94.3 mt -75.85 90.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.755 -0.832 . . . . 0.90000000000000002 108.755 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.45 -14.94 47.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.919 -1.037 . . . . 1.1799999999999999 112.174 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.654 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -158.29 165.28 35.19 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.889 0.376 . . . . 1.6200000000000001 111.144 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -153.81 142.72 21.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.057 -0.52 . . . . 1.3999999999999999 110.82 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.499 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 4.7 mtt -56.43 -30.06 62.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.09 -0.504 . . . . 1.74 111.395 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.509 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 58.55 58.19 3.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.291 0.567 . . . . 3.48 110.462 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.86 -34.7 0.18 Allowed Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.568 -0.742 . . . . 1.3600000000000001 112.269 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.09 -163.49 7.7 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.117 -0.563 . . . . 1.1599999999999999 112.254 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.604 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 32.1 Cg_exo -58.91 -28.84 88.68 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.826 2.351 . . . . 1.1399999999999999 113.559 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -50.15 68.38 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.635 0.255 . . . . 1.1200000000000001 111.312 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -77.97 -36.85 48.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.209 -0.451 . . . . 3.1299999999999999 110.786 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -54.38 -47.23 72.9 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.15 -0.477 . . . . 2.46 111.472 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -69.07 -50.47 48.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.326 -0.397 . . . . 1.95 110.959 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.27 58.93 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.976 -0.63 . . . . 1.8100000000000001 112.77 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.778 ' CB ' HG13 ' A' ' 21' ' ' VAL . 12.9 mtpt -75.99 -41.9 49.8 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.641 0.258 . . . . 2.6400000000000001 110.951 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.892 ' HG ' HG11 ' A' ' 21' ' ' VAL . 29.5 mt -87.03 120.66 28.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.266 -0.425 . . . . 1.1399999999999999 110.654 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 25.9 m-80 -137.36 158.61 44.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 2.2200000000000002 110.932 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.046 HD13 HG22 ' A' ' 49' ' ' ILE . 32.6 mm -64.87 143.29 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.975 0.417 . . . . 1.3200000000000001 111.602 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.84 57.74 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.583 -0.735 . . . . 1.0700000000000001 112.857 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.592 ' HB3' HD12 ' A' ' 103' ' ' ILE . 20.1 m-20 -115.45 146.62 41.47 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.96 0.38 . . . . 1.45 110.08 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 48' ' ' ILE . 1.4 mt-30 -109.89 124.65 51.72 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.042 0.386 . . . . 1.8700000000000001 112.042 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.668 HG23 HG22 ' A' ' 103' ' ' ILE . 6.5 mt -84.48 117.96 30.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.60999999999999999 110.924 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.744 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -84.39 -41.43 16.71 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.116 -0.493 . . . . 0.97999999999999998 111.824 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.2 p -151.24 148.57 28.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.708 0.29 . . . . 1.4299999999999999 111.353 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 70' ' ' ILE . 2.2 mp -127.15 109.92 21.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.75 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 55.5 40.37 31.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.944 -0.571 . . . . 2.1299999999999999 111.554 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.54 -25.45 27.19 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.89 -0.671 . . . . 1.05 113.523 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.633 HG21 HG23 ' A' ' 89' ' ' ILE . 2.6 m -79.4 102.0 8.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.139 0.47 . . . . 0.91000000000000003 110.767 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m -71.0 111.1 6.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.035 -0.53 . . . . 1.46 111.61 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.656 ' HA ' HD21 ' A' ' 81' ' ' LEU . 10.9 mt -76.91 -17.04 59.18 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.797 -0.638 . . . . 0.82999999999999996 111.215 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.822 HG22 HG22 ' A' ' 46' ' ' THR . 15.9 t -62.72 114.85 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.704 -0.225 . . . . 1.48 111.118 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.12 -48.1 0.97 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.932 -0.651 . . . . 1.02 113.242 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -77.2 156.39 81.74 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.754 0.311 . . . . 1.22 111.467 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.93 -179.07 2.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.936 2.424 . . . . 1.24 113.309 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -66.38 -49.35 67.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.67 -0.696 . . . . 1.6399999999999999 111.771 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -52.12 -45.62 65.02 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.547 -0.297 . . . . 1.9199999999999999 110.79 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.636 HG22 HD13 ' A' ' 81' ' ' LEU . 23.1 m -66.46 -45.79 78.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 1.26 110.716 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.489 ' HA ' HG13 ' A' ' 89' ' ' ILE . 59.2 m -57.0 -45.55 82.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.606 0.241 . . . . 0.85999999999999999 111.166 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.596 ' HA ' HD11 ' A' ' 35' ' ' ILE . 13.6 mt-30 -59.13 -44.06 92.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.399 -0.364 . . . . 1.99 110.544 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 t -64.34 -32.72 74.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.422 -0.354 . . . . 1.8700000000000001 111.054 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG23 HG21 ' A' ' 76' ' ' THR . 1.1 mm -61.89 -49.86 82.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.317 -0.401 . . . . 0.90000000000000002 110.801 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.051 HG21 HD13 ' A' ' 201' ' ' ILE . 49.7 mt -71.99 -43.33 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.72999999999999998 110.774 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.732 ' HG3' HG22 ' A' ' 201' ' ' ILE . 8.8 mtpt -55.73 -31.54 62.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.1 -0.5 . . . . 2.9399999999999999 111.099 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.3 -44.3 98.25 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.92 -0.582 . . . . 1.03 112.348 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -88.23 57.73 4.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.263 0.554 . . . . 1.1899999999999999 110.696 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.655 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.81 -33.99 18.43 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.557 -0.747 . . . . 2.2000000000000002 110.859 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.78 61.44 0.81 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.379 -0.373 . . . . 2.5 111.656 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.554 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.2 pt20 -127.34 164.96 20.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.283 -0.417 . . . . 2.6699999999999999 110.735 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.4 p -97.75 -13.83 21.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.482 0.549 . . . . 1.6599999999999999 112.482 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.53 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.4 ttm180 -145.62 132.95 20.6 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.282 . . . . 4.2199999999999998 111.176 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.913 HG12 HD21 ' A' ' 101' ' ' LEU . 2.0 t -112.99 104.29 16.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.279 -0.419 . . . . 1.02 111.282 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.44 125.56 38.11 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.08 -0.509 . . . . 1.6000000000000001 109.736 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -144.39 116.22 8.26 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.015 0.436 . . . . 0.84999999999999998 112.135 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.56 95.86 10.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.706 -0.849 . . . . 1.6000000000000001 108.706 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.668 HG22 HG23 ' A' ' 70' ' ' ILE . 1.6 pt -118.6 160.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.75 112.389 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.744 HG23 ' SD ' ' A' ' 71' ' ' MET . 81.9 t -102.59 108.0 23.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.773 -0.649 . . . . 1.3999999999999999 109.586 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.454 ' C ' ' HD3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -74.7 116.24 15.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.842 -0.617 . . . . 2.5499999999999998 111.66 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.516 ' N ' ' HD3' ' A' ' 107' ' ' PRO . 17.6 t -129.12 54.84 15.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.747 -0.661 . . . . 1.96 110.83 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 106' ' ' CYS . 75.5 Cg_endo -89.93 114.64 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.965 2.443 . . . . 2.8300000000000001 112.703 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 185' ' ' PRO . 21.9 Cg_exo -64.98 111.88 1.86 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.651 2.234 . . . . 1.8 111.863 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 183' ' ' THR . 21.8 t -99.71 123.34 52.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.275 -0.421 . . . . 1.6699999999999999 111.317 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -106.04 136.3 45.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.82999999999999996 110.634 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.8 m -90.91 111.81 23.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 1.0700000000000001 110.268 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.654 ' HB ' ' HG2' ' A' ' 181' ' ' MET . 38.5 t -91.5 106.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.986 -0.552 . . . . 1.29 111.218 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 180' ' ' HIS . 0.9 OUTLIER -102.65 92.78 4.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.167 -0.47 . . . . 1.4099999999999999 109.991 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.724 HG21 HD23 ' A' ' 123' ' ' LEU . 3.2 mt -105.37 104.47 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.131 0.491 . . . . 0.91000000000000003 111.275 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.522 ' O ' HG21 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -82.38 135.21 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.608 -0.724 . . . . 3.3399999999999999 110.971 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -129.0 108.54 18.16 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.16 -0.473 . . . . 2.9100000000000001 110.929 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 116' ' ' ARG . 35.7 Cg_endo -64.96 -37.04 35.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.55 2.167 . . . . 2.2000000000000002 112.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -139.79 163.46 32.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.82 0.343 . . . . 2.3300000000000001 111.037 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.514 HD12 HG11 ' A' ' 176' ' ' VAL . 0.5 OUTLIER -70.99 -18.01 62.62 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.094 -0.503 . . . . 1.71 111.638 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -93.21 18.87 8.78 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.68 0.252 . . . . 4.4900000000000002 111.68 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -102.35 135.71 43.47 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.749 0.309 . . . . 2.5699999999999998 110.847 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.83 126.4 35.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.136 -0.484 . . . . 2.6400000000000001 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.755 HD22 HD13 ' A' ' 172' ' ' LEU . 2.0 mp -62.35 -49.47 75.46 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.267 -0.424 . . . . 1.5700000000000001 110.951 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 135' ' ' LEU . . . 107.49 55.78 0.62 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.98 -0.628 . . . . 1.47 112.97 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 172' ' ' LEU . 1.3 p90 -178.73 171.49 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.726 0.298 . . . . 2.1299999999999999 111.115 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -131.76 127.1 36.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.307 -0.406 . . . . 1.4199999999999999 110.848 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.77 HG21 HG21 ' A' ' 168' ' ' ILE . 7.2 p -109.19 128.84 64.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 0.83999999999999997 111.027 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.21 88.41 2.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.115 -0.493 . . . . 2.6200000000000001 110.678 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.548 ' O ' HD11 ' A' ' 168' ' ' ILE . 1.4 m-80 66.64 -69.79 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.529 -0.76 . . . . 1.9299999999999999 111.966 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.549 ' O ' HD13 ' A' ' 131' ' ' ILE . . . -139.04 -3.32 1.72 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.363 -0.922 . . . . 1.3600000000000001 114.065 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.995 HD12 ' HB2' ' A' ' 186' ' ' ALA . 26.0 mm -123.76 150.7 28.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 117.822 0.811 . . . . 1.3600000000000001 111.586 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.808 HD11 HG13 ' A' ' 152' ' ' ILE . 5.0 mp -99.76 137.36 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.793 -0.639 . . . . 0.87 110.712 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -119.59 -59.49 1.81 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.397 -0.365 . . . . 1.73 111.559 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -89.08 154.21 20.36 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.839 0.352 . . . . 1.6000000000000001 111.29 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.747 HD11 HG13 ' A' ' 146' ' ' VAL . 0.7 OUTLIER -164.63 127.84 2.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.993 -0.549 . . . . 1.8200000000000001 111.031 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 19.6 mtp -78.77 122.25 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.118 -0.492 . . . . 2.4300000000000002 110.707 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -65.08 110.32 2.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.247 -0.433 . . . . 4.6299999999999999 110.858 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.46 27.2 33.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.106 -0.569 . . . . 1.54 112.822 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -96.34 -169.83 34.62 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.946 -0.645 . . . . 1.3 112.347 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.522 HG21 ' O ' ' A' ' 115' ' ' ARG . 1.1 mt -78.02 -44.81 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.537 0.208 . . . . 1.1299999999999999 110.942 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -58.9 -44.48 91.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.322 -0.399 . . . . 0.89000000000000001 110.607 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -68.88 -39.48 79.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.001 -0.545 . . . . 2.3199999999999998 111.057 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -39.75 91.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.553 -0.294 . . . . 3.3999999999999999 111.495 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.6 -66.1 2.71 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.155 -0.545 . . . . 0.87 112.834 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.07 -31.76 0.03 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.828 -0.701 . . . . 0.76000000000000001 113.699 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -42.78 137.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.93 0.395 . . . . 1.6000000000000001 111.807 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -144.84 143.64 30.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.907 -0.588 . . . . 3.8300000000000001 110.938 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.88 114.22 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.209 -0.45 . . . . 1.3600000000000001 110.385 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 186' ' ' ALA . . . 119.33 -20.4 9.64 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 121.082 -0.58 . . . . 1.0600000000000001 112.29 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.412 ' HB2' HD13 ' A' ' 132' ' ' ILE . 16.3 m170 -71.04 -174.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.962 0.411 . . . . 1.2 110.787 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 2.8 ttt180 -141.13 90.7 2.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 2.8199999999999998 110.623 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.808 HG13 HD11 ' A' ' 132' ' ' ILE . 19.2 mt -53.5 136.66 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.455 -0.339 . . . . 0.78000000000000003 110.384 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.911 HG22 ' HB ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER -132.93 -84.55 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.951 0.723 . . . . 1.05 112.951 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.42 90.06 7.85 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.204 0.816 . . . . 2.3300000000000001 113.204 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.85 HG23 ' HB3' ' A' ' 181' ' ' MET . 1.8 mt -90.48 105.47 16.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 1.0700000000000001 110.735 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 55.03 36.95 28.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.936 -0.575 . . . . 2.02 111.463 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.36 -3.5 79.48 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.958 -0.639 . . . . 1.4399999999999999 113.72 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -108.53 115.48 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.25 0.525 . . . . 2.4500000000000002 110.84 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.22 107.94 7.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.197 -0.456 . . . . 2.0699999999999998 111.027 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 155' ' ' ILE . 15.4 m -102.21 3.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 1.23 111.828 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.911 ' HB ' HG22 ' A' ' 153' ' ' ILE . 9.4 p -51.24 -37.93 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.58 0.228 . . . . 1.98 111.468 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.73 30.91 6.76 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.932 0.396 . . . . 1.49 110.608 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.49 HG23 ' HD3' ' A' ' 167' ' ' LYS . 73.3 m -111.62 143.74 29.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.059 -0.519 . . . . 1.28 110.987 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.477 ' HD2' HG23 ' A' ' 163' ' ' THR . 51.7 Cg_exo -54.8 154.0 22.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.024 2.483 . . . . 1.4399999999999999 112.961 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -62.45 -39.38 93.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.067 -0.515 . . . . 1.79 111.916 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.02 -38.6 89.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.718 -0.219 . . . . 2.9500000000000002 111.388 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -65.63 -50.23 65.77 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.441 -0.345 . . . . 2.52 111.077 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.77 HG21 HG21 ' A' ' 127' ' ' VAL . 8.6 mt -58.23 -46.4 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.83 0.348 . . . . 0.97999999999999998 110.824 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 t -60.32 -32.81 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.863 -0.608 . . . . 1.05 110.459 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -64.09 -51.05 65.89 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.575 -0.284 . . . . 2.0899999999999999 111.344 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 167' ' ' LYS . 3.6 mp -53.66 -56.37 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.827 0.346 . . . . 1.04 110.236 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.755 HD13 HD22 ' A' ' 123' ' ' LEU . 1.9 mt -61.24 -30.85 70.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.478 -0.783 . . . . 0.94999999999999996 111.26 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.1 t -69.98 -26.97 64.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.702 -0.226 . . . . 1.76 110.748 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -125.69 28.55 6.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.609 -0.269 . . . . 1.8799999999999999 111.69 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 179' ' ' ILE . . . -109.69 52.1 0.73 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.916 0.389 . . . . 1.5900000000000001 110.951 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.514 HG11 HD12 ' A' ' 119' ' ' LEU . 7.5 m -59.17 137.45 21.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.033 -0.53 . . . . 1.6299999999999999 111.495 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 126.71 -98.16 0.51 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.823 -0.626 . . . . 1.0800000000000001 112.121 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.413 ' HB3' ' NE2' ' A' ' 180' ' ' HIS . 21.2 mt-10 -148.08 93.41 2.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.753 0.311 . . . . 2.3100000000000001 110.827 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 175' ' ' ALA . 1.7 mt -71.37 113.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.317 -0.402 . . . . 0.90000000000000002 110.777 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.568 ' CD2' ' HG ' ' A' ' 113' ' ' LEU . 23.6 m170 -112.62 115.28 28.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 3.3999999999999999 109.917 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.85 ' HB3' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -138.98 169.23 18.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.135 0.493 . . . . 1.22 112.205 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 148.05 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.383 -0.826 . . . . 2.2599999999999998 109.66 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 152' ' ' ILE . 70.6 p -136.21 125.41 24.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.80000000000000004 111.525 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -96.07 178.52 1.39 Allowed Pre-proline 0 C--O 1.224 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.3999999999999999 110.274 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.573 ' HG3' ' HD2' ' A' ' 108' ' ' PRO . 70.0 Cg_endo -88.23 125.08 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.248 1.965 . . . . 1.47 112.303 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.995 ' HB2' HD12 ' A' ' 131' ' ' ILE . . . -82.51 -167.4 1.59 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.472 -0.331 . . . . 1.9399999999999999 111.057 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -56.85 148.96 19.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.528 -0.305 . . . . 3.02 111.409 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.7 132.86 49.02 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 6.6699999999999999 111.325 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 191' ' ' LEU . 47.2 t80 -89.59 120.13 30.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.971 -0.558 . . . . 8.1199999999999992 110.619 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.843 ' C ' HD22 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -104.21 60.93 0.72 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.27 -0.423 . . . . 8.5800000000000001 111.131 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.843 HD22 ' C ' ' A' ' 190' ' ' ARG . 0.0 OUTLIER 29.24 -90.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.76 0.824 . . . . 6.7999999999999998 112.606 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.74 -45.25 0.74 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.45 0.167 . . . . 7.0 111.224 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.2 p -61.76 169.58 2.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.812 0.339 . . . . 6.5599999999999996 111.55 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 69.9 80.53 0.18 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.989 -0.551 . . . . 5.9299999999999997 111.087 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 -33.21 21.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.924 -0.58 . . . . 6.6799999999999997 111.295 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.84 145.22 40.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.784 0.326 . . . . 5.9400000000000004 110.939 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.37 138.28 63.88 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.117 -0.492 . . . . 4.0800000000000001 110.977 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.961 ' HG2' HG21 ' A' ' 34' ' ' VAL . 36.8 Cg_endo -65.83 167.4 17.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.762 2.308 . . . . 2.0099999999999998 112.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 34' ' ' VAL . 87.6 t -56.49 120.22 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.163 -0.471 . . . . 2.1899999999999999 111.063 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.664 ' CE1' HG23 ' A' ' 34' ' ' VAL . 7.9 m-85 -105.27 112.56 25.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.136 -0.484 . . . . 1.7 111.338 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 1.086 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.433 -0.794 . . . . 0.88 111.418 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.681 0.276 . . . . 2.8799999999999999 111.316 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 71' ' ' MET . 2.1 m-85 -59.0 138.77 57.38 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.173 -0.467 . . . . 1.49 111.274 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.58 126.95 3.11 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.019 0.438 . . . . 1.6299999999999999 111.76 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -69.68 130.01 41.2 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.792 -0.64 . . . . 2.4300000000000002 109.865 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.892 HG11 ' HG ' ' A' ' 64' ' ' LEU . 51.1 t -111.82 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.174 -0.466 . . . . 1.1000000000000001 111.036 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CE1' ' HG2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -99.23 104.68 16.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 1.8600000000000001 110.525 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 99' ' ' VAL . 8.4 mm -105.87 99.24 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.739 -0.664 . . . . 1.1100000000000001 110.72 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HG3' ' CD ' ' A' ' 98' ' ' ARG . 2.8 mp0 -81.77 114.54 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.919 -0.582 . . . . 2.8199999999999998 110.025 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -143.37 -171.61 3.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.392 -0.367 . . . . 1.52 111.471 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -104.45 166.99 10.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.254 -0.43 . . . . 2.1400000000000001 110.689 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -67.66 148.61 51.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 1.95 110.548 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' HA2' ' HD3' ' A' ' 94' ' ' LYS . . . 79.0 10.0 86.59 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.786 -0.721 . . . . 1.0800000000000001 112.598 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 31' ' ' LEU . 25.8 mt-10 -119.05 30.07 7.35 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.995 0.398 . . . . 2.6400000000000001 110.392 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.655 HG23 ' CG ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 17.12 -78.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.619 1.199 . . . . 0.97999999999999998 113.752 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 99' ' ' VAL . 15.0 tp -179.79 -43.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.573 -0.739 . . . . 0.93999999999999995 109.948 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' ' CE ' ' A' ' 53' ' ' MET . . . 88.83 58.48 1.7 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.562 -0.744 . . . . 0.87 113.734 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.086 HG22 HD11 ' A' ' 201' ' ' ILE . 0.7 OUTLIER -149.37 155.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.142 0.496 . . . . 0.79000000000000004 111.804 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.961 HG21 ' HG2' ' A' ' 198' ' ' PRO . 54.3 t -117.42 125.87 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.446 -0.797 . . . . 1.03 109.843 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 87' ' ' GLN . 1.0 OUTLIER -114.51 150.95 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.096 0.474 . . . . 0.89000000000000001 112.159 -179.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' HA ' ' HG ' ' A' ' 83' ' ' LEU . 30.0 m -139.37 169.92 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 115.458 -0.792 . . . . 1.1000000000000001 110.523 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.11 131.44 45.82 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.732 0.301 . . . . 2.1600000000000001 110.811 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.656 ' HA ' HD11 ' A' ' 48' ' ' ILE . 79.6 p -68.38 85.64 0.28 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.921 -0.581 . . . . 1.04 111.511 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.61 0.96 89.38 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.02 -0.609 . . . . 1.4099999999999999 113.725 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.739 ' CZ3' HD12 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -61.78 -159.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.54 0.336 . . . . 1.3300000000000001 110.56 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -54.21 -22.79 22.98 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.722 -0.752 . . . . 1.26 112.363 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 m 79.95 42.24 0.06 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.762 0.825 . . . . 1.52 111.719 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.739 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 84.9 mt -58.02 -38.46 67.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.917 -1.038 . . . . 1.1899999999999999 109.95 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 46' ' ' THR . 11.6 mt -147.91 98.11 3.86 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 114.728 -1.124 . . . . 1.1399999999999999 108.616 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 62.0 Cg_exo -53.06 90.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.939 2.426 . . . . 1.1399999999999999 113.441 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.822 HG22 HG22 ' A' ' 79' ' ' VAL . 1.5 p -139.59 -154.58 0.53 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.365 -0.379 . . . . 1.27 110.37 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -110.05 139.29 34.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.891 0.377 . . . . 0.92000000000000004 111.338 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.656 HD11 ' HA ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -99.25 137.27 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.83 -0.623 . . . . 0.96999999999999997 111.778 -179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.046 HG22 HD13 ' A' ' 66' ' ' ILE . 94.3 mt -75.85 90.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.755 -0.832 . . . . 0.90000000000000002 108.755 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.45 -14.94 47.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.919 -1.037 . . . . 1.1799999999999999 112.174 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.654 ' C ' HD11 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -158.29 165.28 35.19 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.889 0.376 . . . . 1.6200000000000001 111.144 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.4 ttm -153.81 142.72 21.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.057 -0.52 . . . . 1.3999999999999999 110.82 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.499 ' CE ' ' HA2' ' A' ' 32' ' ' GLY . 4.7 mtt -56.43 -30.06 62.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.09 -0.504 . . . . 1.74 111.395 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.509 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 0.2 OUTLIER 58.55 58.19 3.46 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.291 0.567 . . . . 3.48 110.462 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.86 -34.7 0.18 Allowed Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.568 -0.742 . . . . 1.3600000000000001 112.269 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.09 -163.49 7.7 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.117 -0.563 . . . . 1.1599999999999999 112.254 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.604 ' HB3' ' HB3' ' A' ' 25' ' ' LYS . 32.1 Cg_exo -58.91 -28.84 88.68 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 122.826 2.351 . . . . 1.1399999999999999 113.559 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.58 -50.15 68.38 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.635 0.255 . . . . 1.1200000000000001 111.312 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -77.97 -36.85 48.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.209 -0.451 . . . . 3.1299999999999999 110.786 179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -54.38 -47.23 72.9 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.15 -0.477 . . . . 2.46 111.472 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -69.07 -50.47 48.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.326 -0.397 . . . . 1.95 110.959 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.27 58.93 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.976 -0.63 . . . . 1.8100000000000001 112.77 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.778 ' CB ' HG13 ' A' ' 21' ' ' VAL . 12.9 mtpt -75.99 -41.9 49.8 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.641 0.258 . . . . 2.6400000000000001 110.951 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.892 ' HG ' HG11 ' A' ' 21' ' ' VAL . 29.5 mt -87.03 120.66 28.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.266 -0.425 . . . . 1.1399999999999999 110.654 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 25.9 m-80 -137.36 158.61 44.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 2.2200000000000002 110.932 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.046 HD13 HG22 ' A' ' 49' ' ' ILE . 32.6 mm -64.87 143.29 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 120.975 0.417 . . . . 1.3200000000000001 111.602 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.56 13.84 57.74 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.583 -0.735 . . . . 1.0700000000000001 112.857 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.592 ' HB3' HD12 ' A' ' 103' ' ' ILE . 20.1 m-20 -115.45 146.62 41.47 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.96 0.38 . . . . 1.45 110.08 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 48' ' ' ILE . 1.9 mt-30 -109.89 124.65 51.72 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.042 0.386 . . . . 1.8700000000000001 112.042 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.668 HG23 HG22 ' A' ' 103' ' ' ILE . 6.5 mt -84.48 117.96 30.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.893 -0.594 . . . . 0.60999999999999999 110.924 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.744 ' SD ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -84.39 -41.43 16.71 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.116 -0.493 . . . . 0.97999999999999998 111.824 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 77.2 p -151.24 148.57 28.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.708 0.29 . . . . 1.4299999999999999 111.353 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 70' ' ' ILE . 2.2 mp -127.15 109.92 21.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.75 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 55.5 40.37 31.19 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.944 -0.571 . . . . 2.1299999999999999 111.554 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.54 -25.45 27.19 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.89 -0.671 . . . . 1.05 113.523 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.633 HG21 HG23 ' A' ' 89' ' ' ILE . 2.6 m -79.4 102.0 8.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.139 0.47 . . . . 0.91000000000000003 110.767 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 m -71.0 111.1 6.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.035 -0.53 . . . . 1.46 111.61 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.656 ' HA ' HD21 ' A' ' 81' ' ' LEU . 10.9 mt -76.91 -17.04 59.18 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.797 -0.638 . . . . 0.82999999999999996 111.215 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.822 HG22 HG22 ' A' ' 46' ' ' THR . 15.9 t -62.72 114.85 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.704 -0.225 . . . . 1.48 111.118 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.12 -48.1 0.97 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.932 -0.651 . . . . 1.02 113.242 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -77.2 156.39 81.74 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 120.754 0.311 . . . . 1.22 111.467 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.93 -179.07 2.31 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.936 2.424 . . . . 1.24 113.309 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD23 ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -66.38 -49.35 67.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.67 -0.696 . . . . 1.6399999999999999 111.771 -179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.4 m -52.12 -45.62 65.02 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.547 -0.297 . . . . 1.9199999999999999 110.79 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.636 HG22 HD13 ' A' ' 81' ' ' LEU . 23.1 m -66.46 -45.79 78.53 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 1.26 110.716 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.489 ' HA ' HG13 ' A' ' 89' ' ' ILE . 59.2 m -57.0 -45.55 82.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.606 0.241 . . . . 0.85999999999999999 111.166 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.596 ' HA ' HD11 ' A' ' 35' ' ' ILE . 13.6 mt-30 -59.13 -44.06 92.0 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.399 -0.364 . . . . 1.99 110.544 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 t -64.34 -32.72 74.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.422 -0.354 . . . . 1.8700000000000001 111.054 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG23 HG21 ' A' ' 76' ' ' THR . 1.1 mm -61.89 -49.86 82.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.317 -0.401 . . . . 0.90000000000000002 110.801 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.051 HG21 HD13 ' A' ' 201' ' ' ILE . 49.7 mt -71.99 -43.33 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.288 -0.414 . . . . 0.72999999999999998 110.774 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.732 ' HG3' HG22 ' A' ' 201' ' ' ILE . 8.8 mtpt -55.73 -31.54 62.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.1 -0.5 . . . . 2.9399999999999999 111.099 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.3 -44.3 98.25 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.92 -0.582 . . . . 1.03 112.348 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 90' ' ' ILE . 0.4 OUTLIER -88.23 57.73 4.41 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.263 0.554 . . . . 1.1899999999999999 110.696 179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.655 ' CG ' HG23 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -87.81 -33.99 18.43 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.557 -0.747 . . . . 2.2000000000000002 110.859 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -102.78 61.44 0.81 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.379 -0.373 . . . . 2.5 111.656 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.554 ' OE1' HG22 ' A' ' 99' ' ' VAL . 1.2 pt20 -127.34 164.96 20.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.283 -0.417 . . . . 2.6699999999999999 110.735 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.4 p -97.75 -13.83 21.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.482 0.549 . . . . 1.6599999999999999 112.482 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.53 ' HG2' ' CE1' ' A' ' 22' ' ' PHE . 4.4 ttm180 -145.62 132.95 20.6 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.691 0.282 . . . . 4.2199999999999998 111.176 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.913 HG12 HD21 ' A' ' 101' ' ' LEU . 2.0 t -112.99 104.29 16.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.279 -0.419 . . . . 1.02 111.282 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -93.44 125.56 38.11 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.08 -0.509 . . . . 1.6000000000000001 109.736 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -144.39 116.22 8.26 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.015 0.436 . . . . 0.84999999999999998 112.135 -179.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.56 95.86 10.19 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.706 -0.849 . . . . 1.6000000000000001 108.706 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.668 HG22 HG23 ' A' ' 70' ' ' ILE . 1.6 pt -118.6 160.77 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.938 -0.574 . . . . 0.75 112.389 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.744 HG23 ' SD ' ' A' ' 71' ' ' MET . 81.9 t -102.59 108.0 23.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.773 -0.649 . . . . 1.3999999999999999 109.586 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.454 ' C ' ' HD3' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -74.7 116.24 15.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.842 -0.617 . . . . 2.5499999999999998 111.66 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.516 ' N ' ' HD3' ' A' ' 107' ' ' PRO . 17.6 t -129.12 54.84 15.42 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.747 -0.661 . . . . 1.96 110.83 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 106' ' ' CYS . 75.5 Cg_endo -89.93 114.64 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.965 2.443 . . . . 2.8300000000000001 112.703 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 185' ' ' PRO . 21.9 Cg_exo -64.98 111.88 1.86 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.651 2.234 . . . . 1.8 111.863 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 183' ' ' THR . 21.8 t -99.71 123.34 52.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.275 -0.421 . . . . 1.6699999999999999 111.317 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -106.04 136.3 45.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.066 -0.515 . . . . 0.82999999999999996 110.634 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.8 m -90.91 111.81 23.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.232 -0.44 . . . . 1.0700000000000001 110.268 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.654 ' HB ' ' HG2' ' A' ' 181' ' ' MET . 38.5 t -91.5 106.76 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 115.986 -0.552 . . . . 1.29 111.218 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 180' ' ' HIS . 0.9 OUTLIER -102.65 92.78 4.78 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.167 -0.47 . . . . 1.4099999999999999 109.991 179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.724 HG21 HD23 ' A' ' 123' ' ' LEU . 3.2 mt -105.37 104.47 17.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.131 0.491 . . . . 0.91000000000000003 111.275 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.522 ' O ' HG21 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -82.38 135.21 35.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.608 -0.724 . . . . 3.3399999999999999 110.971 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -129.0 108.54 18.16 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.16 -0.473 . . . . 2.9100000000000001 110.929 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 116' ' ' ARG . 35.7 Cg_endo -64.96 -37.04 35.58 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.55 2.167 . . . . 2.2000000000000002 112.473 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -139.79 163.46 32.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.82 0.343 . . . . 2.3300000000000001 111.037 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.514 HD12 HG11 ' A' ' 176' ' ' VAL . 0.5 OUTLIER -70.99 -18.01 62.62 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.094 -0.503 . . . . 1.71 111.638 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -93.21 18.87 8.78 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.68 0.252 . . . . 4.4900000000000002 111.68 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -102.35 135.71 43.47 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.749 0.309 . . . . 2.5699999999999998 110.847 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.83 126.4 35.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.136 -0.484 . . . . 2.6400000000000001 110.86 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.755 HD22 HD13 ' A' ' 172' ' ' LEU . 2.0 mp -62.35 -49.47 75.46 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.267 -0.424 . . . . 1.5700000000000001 110.951 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 135' ' ' LEU . . . 107.49 55.78 0.62 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.98 -0.628 . . . . 1.47 112.97 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 172' ' ' LEU . 1.3 p90 -178.73 171.49 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.726 0.298 . . . . 2.1299999999999999 111.115 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -131.76 127.1 36.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.307 -0.406 . . . . 1.4199999999999999 110.848 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.77 HG21 HG21 ' A' ' 168' ' ' ILE . 7.2 p -109.19 128.84 64.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 0.83999999999999997 111.027 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.21 88.41 2.93 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.115 -0.493 . . . . 2.6200000000000001 110.678 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.548 ' O ' HD11 ' A' ' 168' ' ' ILE . 1.4 m-80 66.64 -69.79 0.12 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.529 -0.76 . . . . 1.9299999999999999 111.966 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.549 ' O ' HD13 ' A' ' 131' ' ' ILE . . . -139.04 -3.32 1.72 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.363 -0.922 . . . . 1.3600000000000001 114.065 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.995 HD12 ' HB2' ' A' ' 186' ' ' ALA . 26.0 mm -123.76 150.7 28.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 117.822 0.811 . . . . 1.3600000000000001 111.586 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.808 HD11 HG13 ' A' ' 152' ' ' ILE . 5.0 mp -99.76 137.36 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 115.793 -0.639 . . . . 0.87 110.712 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -119.59 -59.49 1.81 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.397 -0.365 . . . . 1.73 111.559 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -89.08 154.21 20.36 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.839 0.352 . . . . 1.6000000000000001 111.29 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.747 HD11 HG13 ' A' ' 146' ' ' VAL . 0.7 OUTLIER -164.63 127.84 2.4 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.993 -0.549 . . . . 1.8200000000000001 111.031 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 19.6 mtp -78.77 122.25 25.8 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.118 -0.492 . . . . 2.4300000000000002 110.707 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -65.08 110.32 2.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.247 -0.433 . . . . 4.6299999999999999 110.858 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.46 27.2 33.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.106 -0.569 . . . . 1.54 112.822 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -96.34 -169.83 34.62 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.946 -0.645 . . . . 1.3 112.347 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.522 HG21 ' O ' ' A' ' 115' ' ' ARG . 1.1 mt -78.02 -44.81 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.537 0.208 . . . . 1.1299999999999999 110.942 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.528 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -58.9 -44.48 91.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.322 -0.399 . . . . 0.89000000000000001 110.607 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -68.88 -39.48 79.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.001 -0.545 . . . . 2.3199999999999998 111.057 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -39.75 91.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.553 -0.294 . . . . 3.3999999999999999 111.495 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.6 -66.1 2.71 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.155 -0.545 . . . . 0.87 112.834 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -174.07 -31.76 0.03 OUTLIER Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.828 -0.701 . . . . 0.76000000000000001 113.699 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.747 HG13 HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -42.78 137.19 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.93 0.395 . . . . 1.6000000000000001 111.807 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -144.84 143.64 30.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.907 -0.588 . . . . 3.8300000000000001 110.938 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 49.0 t -64.88 114.22 2.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.209 -0.45 . . . . 1.3600000000000001 110.385 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 186' ' ' ALA . . . 119.33 -20.4 9.64 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 121.082 -0.58 . . . . 1.0600000000000001 112.29 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.412 ' HB2' HD13 ' A' ' 132' ' ' ILE . 16.3 m170 -71.04 -174.47 0.97 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.962 0.411 . . . . 1.2 110.787 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 130' ' ' GLY . 2.8 ttt180 -141.13 90.7 2.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 2.8199999999999998 110.623 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.808 HG13 HD11 ' A' ' 132' ' ' ILE . 19.2 mt -53.5 136.66 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.455 -0.339 . . . . 0.78000000000000003 110.384 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.911 HG22 ' HB ' ' A' ' 161' ' ' VAL . 0.8 OUTLIER -132.93 -84.55 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.951 0.723 . . . . 1.05 112.951 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -85.42 90.06 7.85 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.204 0.816 . . . . 2.3300000000000001 113.204 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.85 HG23 ' HB3' ' A' ' 181' ' ' MET . 1.8 mt -90.48 105.47 16.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 1.0700000000000001 110.735 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 55.03 36.95 28.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.936 -0.575 . . . . 2.02 111.463 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.36 -3.5 79.48 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.958 -0.639 . . . . 1.4399999999999999 113.72 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -108.53 115.48 30.18 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 117.25 0.525 . . . . 2.4500000000000002 110.84 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.22 107.94 7.65 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.197 -0.456 . . . . 2.0699999999999998 111.027 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.848 HG21 HD11 ' A' ' 155' ' ' ILE . 15.4 m -102.21 3.8 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.619 -0.719 . . . . 1.23 111.828 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.911 ' HB ' HG22 ' A' ' 153' ' ' ILE . 9.4 p -51.24 -37.93 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.58 0.228 . . . . 1.98 111.468 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.73 30.91 6.76 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.932 0.396 . . . . 1.49 110.608 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.49 HG23 ' HD3' ' A' ' 167' ' ' LYS . 73.3 m -111.62 143.74 29.19 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.059 -0.519 . . . . 1.28 110.987 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.477 ' HD2' HG23 ' A' ' 163' ' ' THR . 51.7 Cg_exo -54.8 154.0 22.66 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.024 2.483 . . . . 1.4399999999999999 112.961 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -62.45 -39.38 93.19 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.067 -0.515 . . . . 1.79 111.916 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.02 -38.6 89.29 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.718 -0.219 . . . . 2.9500000000000002 111.388 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.653 ' O ' HD12 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -65.63 -50.23 65.77 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-N 116.441 -0.345 . . . . 2.52 111.077 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.77 HG21 HG21 ' A' ' 127' ' ' VAL . 8.6 mt -58.23 -46.4 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 120.83 0.348 . . . . 0.97999999999999998 110.824 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.1 t -60.32 -32.81 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.863 -0.608 . . . . 1.05 110.459 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -64.09 -51.05 65.89 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.575 -0.284 . . . . 2.0899999999999999 111.344 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 167' ' ' LYS . 3.6 mp -53.66 -56.37 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.827 0.346 . . . . 1.04 110.236 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.755 HD13 HD22 ' A' ' 123' ' ' LEU . 1.9 mt -61.24 -30.85 70.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.478 -0.783 . . . . 0.94999999999999996 111.26 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.1 t -69.98 -26.97 64.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.702 -0.226 . . . . 1.76 110.748 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -125.69 28.55 6.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.609 -0.269 . . . . 1.8799999999999999 111.69 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 179' ' ' ILE . . . -109.69 52.1 0.73 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.916 0.389 . . . . 1.5900000000000001 110.951 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.514 HG11 HD12 ' A' ' 119' ' ' LEU . 7.5 m -59.17 137.45 21.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.033 -0.53 . . . . 1.6299999999999999 111.495 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 126.71 -98.16 0.51 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.823 -0.626 . . . . 1.0800000000000001 112.121 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.413 ' HB3' ' NE2' ' A' ' 180' ' ' HIS . 21.2 mt-10 -148.08 93.41 2.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.753 0.311 . . . . 2.3100000000000001 110.827 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 175' ' ' ALA . 1.7 mt -71.37 113.68 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.317 -0.402 . . . . 0.90000000000000002 110.777 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.568 ' CD2' ' HG ' ' A' ' 113' ' ' LEU . 23.6 m170 -112.62 115.28 28.35 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.193 -0.458 . . . . 3.3999999999999999 109.917 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.85 ' HB3' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -138.98 169.23 18.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.135 0.493 . . . . 1.22 112.205 -179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 148.05 37.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.383 -0.826 . . . . 2.2599999999999998 109.66 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 152' ' ' ILE . 70.6 p -136.21 125.41 24.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.80000000000000004 111.525 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -96.07 178.52 1.39 Allowed Pre-proline 0 C--O 1.224 -0.252 0 CA-C-N 115.677 -0.692 . . . . 1.3999999999999999 110.274 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.573 ' HG3' ' HD2' ' A' ' 108' ' ' PRO . 70.0 Cg_endo -88.23 125.08 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.248 1.965 . . . . 1.47 112.303 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.995 ' HB2' HD12 ' A' ' 131' ' ' ILE . . . -82.51 -167.4 1.59 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.472 -0.331 . . . . 1.9399999999999999 111.057 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -56.85 148.96 19.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.528 -0.305 . . . . 3.02 111.409 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.7 132.86 49.02 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.181 -0.463 . . . . 6.6699999999999999 111.325 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 191' ' ' LEU . 47.2 t80 -89.59 120.13 30.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.971 -0.558 . . . . 8.1199999999999992 110.619 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.843 ' C ' HD22 ' A' ' 191' ' ' LEU . 0.1 OUTLIER -104.21 60.93 0.72 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.27 -0.423 . . . . 8.5800000000000001 111.131 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.843 HD22 ' C ' ' A' ' 190' ' ' ARG . 0.0 OUTLIER 29.24 -90.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.76 0.824 . . . . 6.7999999999999998 112.606 179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.74 -45.25 0.74 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.45 0.167 . . . . 7.0 111.224 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 28.2 p -61.76 169.58 2.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.812 0.339 . . . . 6.5599999999999996 111.55 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 69.9 80.53 0.18 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.989 -0.551 . . . . 5.9299999999999997 111.087 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 -33.21 21.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.924 -0.58 . . . . 6.6799999999999997 111.295 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.84 145.22 40.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.784 0.326 . . . . 5.9400000000000004 110.939 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.37 138.28 63.88 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.117 -0.492 . . . . 4.0800000000000001 110.977 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.961 ' HG2' HG21 ' A' ' 34' ' ' VAL . 36.8 Cg_endo -65.83 167.4 17.65 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.762 2.308 . . . . 2.0099999999999998 112.455 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 34' ' ' VAL . 87.6 t -56.49 120.22 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.163 -0.471 . . . . 2.1899999999999999 111.063 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.664 ' CE1' HG23 ' A' ' 34' ' ' VAL . 7.9 m-85 -105.27 112.56 25.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.136 -0.484 . . . . 1.7 111.338 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 1.086 HD11 HG22 ' A' ' 33' ' ' VAL . 2.1 pp . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.433 -0.794 . . . . 0.88 111.418 179.65 . . . . . . . . 1 1 . 1 stop_ save_